Alpha Centric Advisors LLC Morphic Holding, Inc. Transaction History

Alpha Centric Advisors LLC

  • $121 Million
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 08, 2022
BUY
$22.23 - $33.37 $233,415 - $350,385
10,500 Added 190.91%
16,000 $453,000
Q1 2021

Mar 09, 2022
BUY
$29.77 - $84.85 $96,752 - $275,762
3,250 Added 144.44%
5,500 $348,000
Q4 2020

Mar 11, 2022
BUY
$25.66 - $34.55 $57,735 - $77,737
2,250 New
2,250 $75,000

Others Institutions Holding MORF

# of Institutions
140
Shares Held
38.7M
Call Options Held
4.2K
Put Options Held
200K
View Full List

About Morphic Holding, Inc.

MORF Quotes by TradingView
  • Ticker MORF
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,477,100
  • Market Cap $2.19B
  • Description
  • Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Its lead product candidates are MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation that is in Phase 1 clinical ...
More about MORF
Track This Portfolio

Track Alpha Centric Advisors LLC Portfolio

Follow Alpha Centric Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpha Centric Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alpha Centric Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email